Balancing Cancer Immunotherapy Efficacy and Toxicity

Anti–programmed cell death-1 receptor/programmed cell death-1 receptor ligand–directed therapies are transforming cancer care, with durable antitumor responses observed in multiple cancer types. Toxicities arising from therapy are autoimmune in nature and may affect essentially any organ system. The...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Johnson, Douglas B., Jakubovic, Baruch D., Sibaud, Vincent, Sise, Meghan E.
Materialtyp: Online Artikel Text
Språk:English
Publicerad: American Academy of Allergy, Asthma & Immunology 2020
Ämnen:
Review and Feature Article
Länkar:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318967/
https://www.ncbi.nlm.nih.gov/pubmed/32599218
http://dx.doi.org/10.1016/j.jaip.2020.06.028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318967/
https://www.ncbi.nlm.nih.gov/pubmed/32599218
http://dx.doi.org/10.1016/j.jaip.2020.06.028

Liknande verk